Picture of Pennant group logo

PNTG — Pennant group News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Pennant Group Q2 revenue beats estimates on home health and hospice growth

Pennant Group Q2 revenue beats estimates on home health and hospice growth


Overview

  • US home health and senior care provider's Q2 revenue rose 36%, beating analyst expectations

  • Adjusted EPS for Q2 beat analyst expectations

  • Company raised 2026 guidance for revenue, adjusted EPS, and adjusted EBITDA


Outlook

  • Pennant Group raises 2026 revenue guidance to $1.171 bln-$1.190 bln

  • Company sees 2026 adj EPS at $1.34-$1.41

  • Pennant expects 2026 adj EBITDA of $94.4 mln-$98.0 mln


Result Drivers

  • HOME HEALTH AND HOSPICE GROWTH - Q2 revenue in this segment rose 43% year-over-year, driven by a 62% increase in total home health admissions and a 40% rise in hospice average daily census

  • RECENT ACQUISITIONS - Integration of newly acquired operations, particularly in the southeast, contributed to revenue growth, with management noting the process is ahead of expectations

  • SENIOR LIVING IMPROVEMENTS - Senior living services revenue rose 13% year-over-year, supported by higher occupancy and increased average monthly revenue per occupied room


Company press release: ID:nGNX27BXZk


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$298 mln

$288.71 mln (7 Analysts)

Q2 Adjusted EPS

Beat

$0.36

$0.33 (7 Analysts)

Q2 EPS

$0.25

Q2 Net Income

$9.08 mln


Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy."

  • Wall Street's median 12-month price target for The Pennant Group, Inc. is $43.50, about 12.7% above its August 4 closing price of $38.61

  • The stock recently traded at 26 times the next 12-month earnings vs. a P/E of 22 three months ago


Reuters Recommended Reads

  • Aug 3 - Addus HomeCare Q2 adjusted profit beats estimates

  • Aug 4 - Canada's Sienna Senior Living Q2 revenue rises on acquisitions and occupancy growth

  • Aug 3 - Sabra Health Care REIT reiterates 2026 guidance as senior housing NOI rises


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Pennant group

See all news